ABO Incompatibility in the Newborn

On this page
  1. Direct answer
  2. What you must remember
  3. ABO disease compared with Rh disease
  4. Where the exam tries to catch you
  5. Frequently asked questions
  6. Related topics

Direct answer

ABO incompatibility in the newborn is haemolysis of the baby's red cells by maternal anti-A or anti-B antibodies, most often when a group O mother carries a group A or B baby. The haemolysis is usually mild, producing early jaundice and spherocytes on the blood film, and hydrops is rare. Unlike Rh disease, it can affect a first pregnancy, is not prevented by anti-D, and is usually treated with phototherapy.

What you must remember

  • Setting: a group O mother with a group A or B baby, because group O women have naturally occurring IgG anti-A and anti-B antibodies.
  • Why it is milder: A and B antigens are less developed on fetal red cells, and the maternal antibodies are less potent, so haemolysis is usually modest.
  • Onset: jaundice appearing within the first 24 hours of life, earlier than physiological jaundice.
  • Blood film: spherocytes, reflecting antibody-mediated loss of red cell membrane, support the diagnosis.
  • Direct Coombs test: often weak or negative, so a negative result does not exclude ABO disease.
  • Management: phototherapy for bilirubin above gestation-specific thresholds, with exchange transfusion needed rarely.
  • Prevention: there is no anti-D prophylaxis, and monitoring of bilirubin and haemoglobin is the main safeguard.

ABO disease compared with Rh disease

Examiners often ask students to tell ABO disease from Rh disease, because the two present in similar ways in a jaundiced newborn. The table sets out the differences that matter for diagnosis and for prevention.

Feature ABO incompatibility Rh disease
Usual mother Group O Rh-negative
First pregnancy Can be affected Usually spared
Direct Coombs test Often weak or negative Usually positive
Hydrops Rare Can occur in severe disease
Prevention Not prevented by anti-D Prevented by anti-D

ABO disease is common but usually mild, so its main risk is an unplanned rise in bilirubin rather than fetal anaemia. Rh disease is less common but potentially dangerous, which is why its prevention is so carefully scheduled.

The difference in severity comes largely from antigen density, because fetal red cells carry fewer A and B sites than strongly expressed D antigen sites, so less antibody binds. Students should remember that the film and the bilirubin curve, rather than the Coombs test, usually guide the decision to treat.

Where the exam tries to catch you

ABO stems usually test the direct Coombs result, the film and the role of anti-D.

  • Trap: expecting a positive direct Coombs test in every ABO baby. Correct: the direct Coombs test is often weak or negative, so the diagnosis rests on the clinical picture, the blood groups and the blood film.
  • Trap: giving anti-D to a group O mother whose baby is group A. Correct: anti-D prevents Rh disease and has no role in ABO disease, which is not prevented in this way.
  • Trap: assuming ABO disease always causes severe anaemia. Correct: it is usually mild, though the baby's jaundice still needs close monitoring and phototherapy when indicated.

Frequently asked questions

Why are group O mothers at risk of ABO incompatibility in their babies?

Group O mothers are at risk of ABO incompatibility because they have naturally occurring IgG anti-A and anti-B antibodies, which can cross the placenta into a group A or B fetus. The risk is realised only when the baby's blood group differs from the mother's.

How does ABO haemolytic disease differ from Rh disease?

ABO haemolytic disease is usually milder than Rh disease and can affect a first pregnancy, often with a weak or negative direct Coombs test. Rh disease is usually more severe, can cause hydrops, and is prevented by anti-D immunoglobulin.

Does ABO incompatibility need anti-D prophylaxis?

ABO incompatibility does not need anti-D prophylaxis, because anti-D is used to prevent Rh disease and does not act on anti-A or anti-B antibodies. Management of ABO disease focuses on monitoring bilirubin and treating jaundice with phototherapy.

What is the blood film finding in ABO haemolytic disease?

The blood film in ABO haemolytic disease often shows spherocytes, which reflect antibody-mediated loss of red cell membrane. The spherocytes support the diagnosis when the direct Coombs test is weak or negative.

Practise this in the PrepElephant app

Question banks, previous-year questions, mock tests and revision tools — for ABO Incompatibility in the Newborn and NEET-PG Paediatrics. Free to start.

Get the free app WhatsApp